Long-acting triamcinolone acetonide prodrug microcrystals for sustained intra-articular treatment of osteoarthritis

Xiaoyu Wang; Yanliang Dong; Xiaofeng Lin; Xiangyue Deng; Xingwei Li; Xiaoguang Shi; Yaxin Zhou; Xue Yao; Na Yu; Shutao Guo

doi:10.1016/j.jconrel.2026.114868

journal article Jun 01, 2026

Long-acting triamcinolone acetonide prodrug microcrystals for sustained intra-articular treatment of osteoarthritis

Xiaoyu Wang

Yanliang Dong Xiaofeng Lin

Xiangyue Deng Xingwei Li

Xiaoguang Shi Yaxin Zhou Xue Yao

Na Yu

Shutao Guo

Journal of Controlled Release Vol. 394 pp. 114868 · Elsevier BV

View at Publisher Save 10.1016/j.jconrel.2026.114868

Topics

No keywords indexed for this article. Browse by subject →

References

35

[1]

Osteoarthritis

Su'an Tang, Changqing Zhang, Win Min Oo et al.

Nature Reviews Disease Primers 2025 10.1038/s41572-025-00594-6

[2]

Dieppe "Pathogenesis and management of pain in osteoarthritis" Lancet (2005) 10.1016/s0140-6736(05)71086-2

[3]

Haber "When should we treat knee osteoarthritis and with which treatments?" Lancet Rheumatol. (2024) 10.1016/s2665-9913(24)00006-7

[4]

Dell’Isola "Osteoarthritis year in review 2025: epidemiology and therapy" Osteoarthr. Cartil. (2025) 10.1016/j.joca.2025.08.015

[5]

Evans "Progress in intra-articular therapy" Nat. Rev. Rheumatol. (2014) 10.1038/nrrheum.2013.159

[6]

Jones "Intra-articular treatment options for knee osteoarthritis" Nat. Rev. Rheumatol. (2019) 10.1038/s41584-018-0123-4

[7]

Oshima "The comparison of dexamethasone and triamcinolone periarticular administration in total knee arthroplasty: retrospective cohort study" BMC Musculoskelet. Disord. (2022) 10.1186/s12891-022-05048-8

[8]

Russell "Triamcinolone acetonide extended-release in patients with osteoarthritis and type 2 diabetes: a randomized, phase 2 study" Rheumatology (Oxford) (2018) 10.1093/rheumatology/key265

[9]

Bensa "Intra-articular corticosteroids for the treatment of osteoarthritis: a systematic review and meta-analysis on the comparison of different molecules and doses" J. Exp. Orthop. (2024) 10.1002/jeo2.12060

[10]

Paik "Triamcinolone acetonide extended-release: a review in osteoarthritis pain of the knee" Drugs (2019) 10.1007/s40265-019-01083-3

[11]

Bodick "An intra-articular, extended-release formulation of triamcinolone acetonide prolongs and amplifies analgesic effect in patients with osteoarthritis of the knee: a randomized clinical trial" J. Bone Joint Surg. (2015) 10.2106/jbjs.n.00918

[12]

Conaghan "Brief report: a phase IIb trial of a novel extended-release microsphere formulation of triamcinolone acetonide for intraarticular injection in knee osteoarthritis" Arthritis Rheum. (2018) 10.1002/art.40364

[13]

Thackaberry "Evaluation of the toxicity of intravitreally injected PLGA microspheres and rods in monkeys and rabbits: effects of depot size on inflammatory response" Invest. Ophthalmol. Vis. Sci. (2017) 10.1167/iovs.16-21334

[14]

Siefen "Assessment of joint pharmacokinetics and consequences for the intraarticular delivery of biologics" J. Control. Release (2022) 10.1016/j.jconrel.2022.06.015

[15]

Tessier "Emerging nanoparticle platforms to improve the administration of glucocorticoids" J. Control. Release (2023) 10.1016/j.jconrel.2023.04.039

[16]

Deng "Chondrocyte membrane-coated nanoparticles promote drug retention and halt cartilage damage in rat and canine osteoarthritis" Sci. Transl. Med. (2024) 10.1126/scitranslmed.adh9751

[17]

Chien "Prodrug approaches for the development of a long-acting drug delivery systems" Adv. Drug Deliv. Rev. (2023) 10.1016/j.addr.2023.114860

[18]

Storgaard "Diclofenac Prodrugs for Intra-articular Depot Injectables: In Vitro Hydrolysis and Species Variation" J. Pharm. Sci. (2020) 10.1016/j.xphs.2020.01.003

[19]

Thing "Simulated synovial fluids for in vitro drug and prodrug release testing of depot injectables intended for joint injection" J. Drug Delivery Sci. Technol. (2019) 10.1016/j.jddst.2018.11.012

[20]

Alidori "Patient-centric long-acting injectable and implantable platformsan industrial perspective" Mol. Pharm. (2024) 10.1021/acs.molpharmaceut.4c00665

[21]

Joint Acidosis and Acid-Sensing Receptors and Ion Channels in Osteoarthritis Pathobiology and Therapy

William N. Martin, Colette Hyde, Adam Yung et al.

Cells 2025 10.3390/cells14201605

[22]

Lombardi "AcidoCEST-UTE MRI reveals an acidic microenvironment in knee osteoarthritis" Int. J. Mol. Sci. (2022) 10.3390/ijms23084466

[23]

Zhou "Subconjunctival injection of microcrystalline prodrug of dexamethasone for long-acting anti-inflammation after phacoemulsification surgery" J. Control. Release (2025) 10.1016/j.jconrel.2024.11.046

[24]

Zhao "Advances in acid-degradable and enzyme-cleavable linkers for drug delivery" Curr. Opin. Chem. Biol. (2025) 10.1016/j.cbpa.2024.102552

[25]

Yu "Modular ketal-linked prodrugs and biomaterials enabled by organocatalytic transisopropenylation of alcohols" Nat. Commun. (2021) 10.1038/s41467-021-25856-1

[26]

Sodeifian "Solubility measurement of triamcinolone acetonide (steroid medication) in supercritical CO2: experimental and thermodynamic modeling" J. Supercrit. Fluids (2024) 10.1016/j.supflu.2023.106119

[27]

Xu "Microcrystals of ketal-linked paliperidone prodrugs for long-acting antipsychotics" Mol. Pharm. (2022) 10.1021/acs.molpharmaceut.2c00348

[28]

Liu "Simultaneous determination of triamcinolone acetonide palmitate and triamcinolone acetonide in beagle dog plasma by UPLC-MS/MS and its application to a long-term pharmacokinetic study of triamcinolone acetonide palmitate lipid emulsion injection" J. Pharm. Biomed. Anal. (2015) 10.1016/j.jpba.2014.11.028

[29]

Heffernan "Polyketal nanoparticles: a new pH-sensitive biodegradable drug delivery vehicle" Bioconjug. Chem. (2005) 10.1021/bc050176w

[30]

Kurono "Esterase-like activity of human serum albumin. VIII. Reaction with amino acid p-nitrophenyl esters" Chem. Pharm. Bull. (1992) 10.1248/cpb.40.2169

[31]

Westhof "Dynamic weight-bearing test during jumping: a sensitive outcome measure of chronic osteoarthritis pain in rats" Heliyon (2021) 10.1016/j.heliyon.2021.e07906

[32]

Kroin "Intraarticular slow-release triamcinolone acetate reduces allodynia in an experimental mouse knee osteoarthritis model" Gene (2016) 10.1016/j.gene.2016.06.049

[33]

Hu "Overview of MMP-13 as a promising target for the treatment of osteoarthritis" Int. J. Mol. Sci. (2021) 10.3390/ijms22041742

[34]

Teng "Cyasterone inhibits IL-1β-mediated apoptosis and inflammation via the NF-κB and MAPK signaling pathways in rat chondrocytes and ameliorates osteoarthritisin vivo" Chin. J. Nat. Med. (2023)

[35]

Han "Association between knee alignment, osteoarthritis disease severity, and subchondral trabecular bone microarchitecture in patients with knee osteoarthritis: a cross-sectional study" Arthritis Res. Ther. (2020) 10.1186/s13075-020-02274-0

Metrics

0

Citations

35

References

Details

Published: Jun 01, 2026
Vol/Issue: 394
Pages: 114868
License: View

Authors

X

Xiaoyu Wang

Qilu University of Technology

Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian 116023, China

School of Physical Science and Technology, ShanghaiTech University, Shanghai 201210, China.

S

Shutao Guo

Funding

National Natural Science Foundation of China

Cite This Article

Xiaoyu Wang, Yanliang Dong, Xiaofeng Lin, et al. (2026). Long-acting triamcinolone acetonide prodrug microcrystals for sustained intra-articular treatment of osteoarthritis. Journal of Controlled Release, 394, 114868. https://doi.org/10.1016/j.jconrel.2026.114868

Long-acting triamcinolone acetonide prodrug microcrystals for sustained intra-articular treatment of osteoarthritis

You May Also Like